Medizinische Universität Graz - Research portal
Selected Publication:
SHR Neuro Cancer Cardio Lipid Metab Microb
Jaksch, W; Likar, R; Aigner, M.
[Ketamine in the therapy of chronic pain and depression].
Wien Med Wochenschr. 2019; 169(15-16): 367-376.
Doi: 10.1007/s10354-019-0695-x
Web of Science
PubMed
FullText
FullText_MUG
- Co-authors Med Uni Graz
- Likar Rudolf
- Altmetrics:
- Dimensions Citations:
- Plum Analytics:
- Scite (citation analytics):
- Abstract:
- Although ketamine has been known and clinically applied for a long time, questions still arise around the many possible indications in which the anesthetic and analgesic substance could be used. In particular, these questions relate to new indications in which ketamine is used in low subanesthetic doses.The mechanism of action at the NMDA receptor clearly distinguishes ketamine from all other analgesics. Possible applications include the prevention of chronic postoperative pain as well as the treatment of neuropathic pain. With the treatment of refractory depression completely new therapeutic areas for ketamine could be established.
- Find related publications in this database (using NLM MeSH Indexing)
- Analgesics - therapeutic use
- Chronic Pain - drug therapy
- Depression - drug therapy
- Humans - administration & dosage
- Ketamine - therapeutic use
- Neuralgia - administration & dosage
- Find related publications in this database (Keywords)
- Pain therapy
- S-Ketamine
- Cancer pain
- Neuropathic pain
- Therapy resistant depression